[ad_1]
The inclusion of CoronaVac, vaccine produced by China Sinovac, by the Ministry of Health In the national immunization plan against covid-19, delivered this Saturday afternoon (12) to the STF (Supreme Federal Court), it is one more chapter in the public dispute between President Jair Bolsonaro (no party) and the governor of São Paulo, João Doria (PSDB).
The Sinovac immunizer is one of 13 vaccines in phase 3 testing, the last one, evaluating safety and efficacy, which “is expected to be acquired by the Ministry of Health,” according to the document. None of them have yet been approved by Anvisa (National Health Surveillance Agency).
This is the second time that the government has officially demonstrated its intention to acquire CoronaVac; The first time, in October, Bolsonaro ended up publicly disapproving of the Minister of Health, Eduardo Pazuello, about the intention to buy 46 million doses of CoronaVac. “The Brazilian people will not be a” guinea pig, “said the president, who called CoronaVac” João Doria’s Chinese vaccine. “
The governor of São Paulo has responded with frequent public demands to the president. After unveiling the state vaccination plan for São Paulo earlier this month, Doria said Bolsonaro “left Brazil” and demanded attitudes from the federal government.
The disclosure of the plan, with a reserve of 4 million doses for other states, generated an uproar between states and municipalities. In total, 11 states and more than 900 municipalities, according to Doria, decided not to wait for the national plan and sought to get the São Paulo government to declare its intention to buy CoronaVac.
This week, in a ministerial meeting with governors, Pazuello and Doria discussed the incorporation of the vaccine into the national plan. Now listed as one of the listed companies.
Anvisa lacks approval
Like the others mentioned, CoronaVac does not have the approval of Anvisa for its distribution in the country. According to the Butantan Institute, the results of phase 3, which show the safety and efficacy of the immunizer, must be delivered to the agency until next Tuesday (15).
Thereafter, Anvisa has up to 30 days (January 15) to provide an answer on the immunizer. The expectation of the São Paulo government is that it be approved, so much so that immunization has already started for January 25 and began to produce doses in São Paulo.
